838 related articles for article (PubMed ID: 7023043)
1. [Intravascular blood coagulation and its role in malignant neoplasms].
Pavlovskiĭ DP
Vopr Onkol; 1981; 27(7):96-103. PubMed ID: 7023043
[No Abstract] [Full Text] [Related]
2. Disseminated Intravascular Coagulation (DIC) in cancer.
Saba HI; Morelli GA; Saba RI
Cancer Treat Res; 2009; 148():137-56. PubMed ID: 19377923
[No Abstract] [Full Text] [Related]
3. [Coagulation in the context of cancer].
Sánchez-Fayos J
Rev Clin Esp; 1983 May; 169(3):153-6. PubMed ID: 6193569
[No Abstract] [Full Text] [Related]
4. [Hemostatic system disorders in malaria (a review of the literature)].
Bronshteĭn AM
Med Parazitol (Mosk); 1981; 50(4):64-72. PubMed ID: 7024773
[No Abstract] [Full Text] [Related]
5. Hemostasis and malignancy.
Francis JL; Biggerstaff J; Amirkhosravi A
Semin Thromb Hemost; 1998; 24(2):93-109. PubMed ID: 9579631
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of fibrinogen degradation products.
Bick RL
Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
[No Abstract] [Full Text] [Related]
7. The role of hypercoagulability in venous and arterial thrombosis.
Wessler S
Cardiovasc Clin; 1971; 3(1):1-16. PubMed ID: 4944368
[No Abstract] [Full Text] [Related]
8. [Regulation of the fluid state of the blood and the problems of pathophysiology].
Kudriashov BA
Probl Gematol Pereliv Krovi; 1979 Jul; 24(7):13-9. PubMed ID: 382181
[No Abstract] [Full Text] [Related]
9. Pathways of coagulation/fibrinolysis activation in malignancy.
Zacharski LR; Wojtukiewicz MZ; Costantini V; Ornstein DL; Memoli VA
Semin Thromb Hemost; 1992 Jan; 18(1):104-16. PubMed ID: 1574711
[TBL] [Abstract][Full Text] [Related]
10. Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis.
Ambrus JL; Ambrus CM; Pickern J; Soldes S; Bross I
J Med; 1975; 6(5-6):433-58. PubMed ID: 130433
[No Abstract] [Full Text] [Related]
11. Coagulation disorders.
Bonnar J
J Clin Pathol Suppl (R Coll Pathol); 1976; 10():35-41. PubMed ID: 1067268
[No Abstract] [Full Text] [Related]
12. [Disseminated intravascular coagulation in malignant neoplasms].
Kato A
Rinsho Ketsueki; 2010 Jan; 51(1):37-43. PubMed ID: 20134138
[No Abstract] [Full Text] [Related]
13. [Thrombohemorrhagic syndrome in oncological patients].
Pavlovskiĭ DP
Klin Med (Mosk); 1981 May; 59(5):16-20. PubMed ID: 7022006
[No Abstract] [Full Text] [Related]
14. Fibrin and cancer.
Costantini V; Zacharski LR
Thromb Haemost; 1993 May; 69(5):406-14. PubMed ID: 8322261
[No Abstract] [Full Text] [Related]
15. [Pathophysiological bases of blood coagulation disorders and the principles for their intensive therapy in surgical patients].
Savel'ev VS; Gologorskiĭ VA; Grinenko TF
Grudn Khir; 1979; (2):9-18. PubMed ID: 428819
[No Abstract] [Full Text] [Related]
16. Blood clotting abnormalities in liver disease.
Aledort LM
Prog Liver Dis; 1976; 5():350-62. PubMed ID: 775547
[No Abstract] [Full Text] [Related]
17. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
Murano G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
[No Abstract] [Full Text] [Related]
18. Pathogenesis of disseminated intravascular coagulation.
Evensen SA; Hjort PF
Hamatol Bluttransfus; 1970; 9():109-20. PubMed ID: 5508063
[No Abstract] [Full Text] [Related]
19. [Products of fibrinogen splitting and their biological significance (literature survey)].
Timoshenko LI
Lab Delo; 1976; (9):515-20. PubMed ID: 63624
[No Abstract] [Full Text] [Related]
20. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
